Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160105025871N2Phase 3Completed
Phase 3 trial of tranexamic acid in postoperative hemorrhage, sponsored by Kerman University of Medical Sciences. Primary endpoint: Postoperative blood loss. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160105025871N2.